REGENXBIO Inc.
RGNX · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
Business Summary
2 Item 1A. Risk Factors 33 Item 1B. Unresolved Staff Comments 69 Item 1C. Cybersecurity 69 Item 2. Properties 70 Item 3. Legal Proceedings 70 Item 4. Mine Safety Disclosures 70 Part II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 71 Item 6. Reserved 71 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 72 Item 7A. Quantitative and Qualitative Disclosures about Market Risk 88 Item 8. F...
Next Earnings
Q2 FY2026 — expected 2026-08-15
Key Facts from Earnings Calls
| Type | Subject | Detail | Quarter |
|---|
| topic_mention | RGNX | discussed_in_filing Cybersecurity | |
| topic_mention | RGNX | discussed_in_filing Cybersecurity | |
| topic_mention | RGNX | discussed_in_filing Cybersecurity | |
| topic_mention | RGNX | discussed_in_filing Cybersecurity | |
Annual Reports (10-K)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2026-03-05 | 2025-12-31 | 0001193125-26-094013 | EDGAR | 108K words |
| 2025-03-13 | 2024-12-31 | 0000950170-25-038770 | EDGAR | — |
| 2024-02-27 | 2023-12-31 | 0000950170-24-021161 | EDGAR | — |
| 2023-02-28 | 2022-12-31 | 0000950170-23-005085 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0001564590-22-008055 | EDGAR | — |
| 2021-03-01 | 2020-12-31 | 0001564590-21-009855 | EDGAR | — |
| 2020-02-26 | 2019-12-31 | 0001564590-20-006826 | EDGAR | — |
| 2019-02-27 | 2018-12-31 | 0001564590-19-004920 | EDGAR | — |
| 2018-03-06 | 2017-12-31 | 0001564590-18-004532 | EDGAR | — |
| 2017-03-07 | 2016-12-31 | 0001564590-17-003576 | EDGAR | — |
Quarterly Reports (10-Q)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2025-11-06 | 2025-09-30 | 0001193125-25-268095 | EDGAR | 37K words |
| 2025-08-07 | 2025-06-30 | 0001193125-25-174953 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0000950170-25-069237 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0000950170-24-122330 | EDGAR | — |
| 2024-08-01 | 2024-06-30 | 0000950170-24-089320 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0000950170-24-055691 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0000950170-23-061144 | EDGAR | — |
| 2023-08-02 | 2023-06-30 | 0000950170-23-037178 | EDGAR | — |
| 2023-05-03 | 2023-03-31 | 0000950170-23-017200 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0000950170-22-021567 | EDGAR | — |
| 2022-08-03 | 2022-06-30 | 0001564590-22-027764 | EDGAR | — |
| 2022-05-04 | 2022-03-31 | 0001564590-22-017878 | EDGAR | — |
Recent Current Reports (8-K)
| Filed | Accession | Source | Full Text |
|---|
| 2026-03-20 | 0001193125-26-117913 | EDGAR | 1K words |
| 2026-03-05 | 0001193125-26-092566 | EDGAR | — |
| 2026-02-10 | 0001193125-26-043342 | EDGAR | — |
| 2026-01-28 | 0001193125-26-026139 | EDGAR | — |
| 2025-11-06 | 0001193125-25-268101 | EDGAR | — |
| 2025-08-18 | 0000950170-25-109829 | EDGAR | — |
| 2025-08-07 | 0001193125-25-174947 | EDGAR | — |
| 2025-06-03 | 0000950170-25-080986 | EDGAR | — |
| 2025-05-19 | 0001193125-25-122456 | EDGAR | — |
| 2025-05-12 | 0000950170-25-069211 | EDGAR | — |
182 total filings indexed. 150 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers
Company Identity
| CIK | 0001590877 |
| Ticker | RGNX |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: 7add404bba5a81a423f9514ce17b28777e27b0555d24de0ff511e8540244afd9
parent: 890f06e51891667faf95f9e47c9dd945d7ae4ad0a568a8c0c531c6d10cffddf7
content hash: 90b7cb5009f5a2cbacf3c6b4506ed5a4b0b31622dcef1055fd6551af8601732c
signed: 2026-04-13T04:47:11.161Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf